Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
AK

WKN: A2P200 | ISIN: KYG0146B1032 | Ticker: 4RY
Tradegate
18.11.26 | 17:20
6,796 Euro
+0,59 % +0,040
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
AKESO INC Chart 1 Jahr
5-Tage-Chart
AKESO INC 5-Tage-Chart
RealtimeGeldBriefZeit
6,7266,83618.11.
6,6966,80818.11.

Aktuelle News zur AKESO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCMBI Cuts AKESO TP to HKD99.34; HARMONi-3 Remains Key Catalyst3
MiAKESO Buys Back 250,000 Shrs for HKD16M on Tue; Board Approves Additional HKD200M Buyback Plan3
DiAKESO (09926): VOLUNTARY ANNOUNCEMENT - PROPOSED ON-MARKET SHARE PURCHASES2
AKESO Aktie jetzt für 0€ handeln
DiAKESO (09926): VOLUNTARY ANNOUNCEMENT - ON-MARKET SHARE PURCHASE9
DiDaiwa Cuts AKESO TP to HKD120, Reiterates Buy; Decline Exceeds Fundamentals3
DiAKESO Spends HKD21 million on Repurchasing 336,000 Shares on Mon2
MoAKESO (09926): VOLUNTARY ANNOUNCEMENT ON-MARKET SHARE PURCHASE1
MoHSI Gains 116 Pts for Day; NEW WORLD DEV Plunges 40%, MINIMAX-W Hits New Low with 18% Drop, AKESO Slumps 22%4
MoChina's Akeso Sinks After US FDA Rejects License Application for Its Cancer Drug21
MoHSI Closes at 23,753, Up 116 pts; HSTI Closes at 3,801, Down 11 pts; AKESO Down over 22%; MENGNIU DAIRY, CKI HOLDINGS, BANK OF CHINA, MIDEA GROUP, COSCO SHIP PORT Hit New Highs; Market Turnover Rises6
MoCiti Cuts AKESO TP to HKD163 as US FDA Rejects New Lung Cancer Drug27
MoNomura Downgrades AKESO to Neutral, Cuts TP to HKD943
MoHSI Up 197 Pts at Half-day; NEW WORLD DEV Once Crashes 47%; MINIMAX-W and Z.AI Each Slump Over 10%; AKESO Plunges 23%16
MoAKESO (09926): ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES1
MoUBS: AKESO Partner Receives FDA Complete Response Letter for ivonescimab Plus Chemotherapy BLA, Slightly Negative2
MoAKESO Plunges Nearly 24%; CLSA Says FDA Non-approval of Ivonescimab Meets Expectations10
MoHSI Opens Up 71 pts; NEW WORLD DEV Resumes Trading, Plunges 45.5%; AKESO Opens Down 15%; JD-SW, BIDU-W Each Open Over 2% Higher22
MoAKESO Plunges as Much as 32% Amid Forced Selling as Ivonescimab Fails to Obtain FDA Approval for US Launch3
06.11.Akeso, Inc.: Phase II Study of Ivonescimab in the Perioperative Setting for Resectable NSCLC Published in Nature Medicine263HONG KONG, Nov. 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that results from a Phase II clinical study evaluating its first-in-class PD-1/VEGF bispecific antibody ivonescimab in...
► Artikel lesen
26.10.AKESO Releases Phase III Study Results of Ivonescimab Combination Therapy for Advanced Biliary Tract Cancer7
1 2 3 4 5 Weiter >>
88 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1